Rating History for Halozyme Therapeutics (HALO) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for HALO
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/29/2026 Corinne Jenkins Maintain Sell
(N/A)		 58.00
(N/A)		  
 		   Details